Children’s hospitals across the U.S. are bracing for capacity strain amid supply issues for a new antibody drug meant to prevent severe illness from respiratory syncytial virus in infants, the Children’s Hospital Association told The Hill in an Oct. 31 report.
Read the full post on Becker's Hospital Review - Healthcare News
